Some risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the I ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

It usually arises from benign serous tumours. There are also several less common subtypes including, but not limited to, mucinous ovarian cancer, endometrioid ovarian cancer, transitional cell ...

Despite our relatively rudimentary understanding of the ovarian cancer epigenome, there is increasing interest in the utilization of epigenetic therapies in the treatment of this disease ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...